Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Oesophagus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06356311
What this trial is testing

Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)

Who this might be right for
Gastroesophageal Cancer
Merck Sharp & Dohme LLC 450
Testing effectiveness (Phase 2)Ended earlyNCT00827671
What this trial is testing

Study of Combination of Cetuximab and Radiotherapy Added to the Standard Treatment for Oesophageal Adenocarcinoma

Who this might be right for
Resectable Esophageal Cancer
P.O. Witteveen 12
Not applicableActive Not RecruitingNCT06642506
What this trial is testing

Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma

Who this might be right for
Esophagus AdenocarcinomaEsophagus CancerMetabolome+5 more
Ludwig-Maximilians - University of Munich 20
Not applicableLooking for participantsNCT06071845
What this trial is testing

Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples

Who this might be right for
Barrett EsophagusBarretts Esophagus With DysplasiaBarrett's Esophagus Without Dysplasia+1 more
Mayo Clinic 450
Testing effectiveness (Phase 2)Study completedNCT00066716
What this trial is testing

Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Weill Medical College of Cornell University 39
Not applicableActive Not RecruitingNCT04295811
What this trial is testing

Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC

Who this might be right for
Barrett EsophagusEsophageal AdenocarcinomaBarretts Esophagus With Dysplasia+1 more
Lucid Diagnostics, Inc. 784
Testing effectiveness (Phase 2)Study completedNCT01158287
What this trial is testing

Sorafenib. ICORG 06-41, V4

Who this might be right for
Esophageal CancerGastric Cancer
Cancer Trials Ireland 54
Testing effectiveness (Phase 2)Ended earlyNCT04604132
What this trial is testing

Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma
Basilea Pharmaceutica 47
Early research (Phase 1)Ended earlyNCT02023541
What this trial is testing

Proton Beam Therapy to Treat Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell CarcinomaAdenocarcinoma Of Esophagus
Washington University School of Medicine 3
Testing effectiveness (Phase 2)Study completedNCT00096031
What this trial is testing

S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
SWOG Cancer Research Network 63
Testing effectiveness (Phase 2)Ended earlyNCT01395537
What this trial is testing

Lapatinib With Carboplatin and Paclitaxel in Esophagus and Gastroesophageal Junction (GEJ)

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal Junction
Case Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Looking for participantsNCT03161522
What this trial is testing

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaOligometastasisStage IV Esophageal Adenocarcinoma AJCC v7+2 more
M.D. Anderson Cancer Center 100
Not applicableStudy completedNCT05069766
What this trial is testing

Preoperative Marking of the Oral Resection Margin in Esophageal Cancer With a Surgical Fiducial Marker - First Experiences

Who this might be right for
Esophagus Cancer, Adenocarcinoma
Rigshospitalet, Denmark 10
Not applicableStudy completedNCT02075905
What this trial is testing

Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management

Who this might be right for
Barrett's EsophagusEsophageal AdenocarcinomaIntestinal Metaplasia+1 more
University of North Carolina, Chapel Hill 111
Testing effectiveness (Phase 2)Ended earlyNCT00447226
What this trial is testing

Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists

Who this might be right for
Cancer
GlaxoSmithKline 32
Not applicableLooking for participantsNCT00288119
What this trial is testing

Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Who this might be right for
Barrett's EsophagusEsophageal Neoplasm
Case Western Reserve University 2,000
Not applicableStudy completedNCT04161781
What this trial is testing

PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

Who this might be right for
Esophagogastric CancerEsophagus CancerEsophageal Cancer+4 more
Memorial Sloan Kettering Cancer Center 10
Early research (Phase 1)Study completedNCT00601692
What this trial is testing

Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center 27
Large-scale testing (Phase 3)Looking for participantsNCT05677490
What this trial is testing

MFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Who this might be right for
Advanced Esophageal AdenocarcinomaAdvanced Gastric AdenocarcinomaAdvanced Gastroesophageal Junction Adenocarcinoma+12 more
Alliance for Clinical Trials in Oncology 382
Large-scale testing (Phase 3)Looking for participantsNCT06203600
What this trial is testing

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Who this might be right for
Advanced Esophageal AdenocarcinomaAdvanced Gastric AdenocarcinomaAdvanced Gastroesophageal Junction Adenocarcinoma+13 more
National Cancer Institute (NCI) 224
Next Page